Contacts:
Novavax
Investors Silvia Taylor and Erika [email protected]
MediaBrandzone / KOGS CommunicationEdna [email protected]
Takeda Pharmaceuticals
Media in Japan Kazumi Kobayashi ’81 (0) 3-3278-2095 [email protected] Media outside Japan Amy Atwood [email protected]
1. Projected capacity is an estimate of Novavax’s existing assumptions only.